Stock PMCB PHARMACYTE BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases PharmaCyte Biotech, Inc.

Equities

PMCB

US71715X2036

Delayed Nasdaq
Other stock markets
 14:51:26 14/05/2024 BST 		5-day change 1st Jan Change
2.1 USD +0.48% Intraday chart for PharmaCyte Biotech, Inc. -4.27% -6.48%
03-18 PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
2023 PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.
AQ
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
BU
PharmaCyte Biotech : Change in Certifying Accountants - Form 8-K
PU
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
BU
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
BU
PharmaCyte Biotech : Certificate of Incorporation/Bylaws - Form 8-K
PU
PharmaCyte Biotech Announces Final Results of Tender Offer
BU
PHARMACYTE BIOTECH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
BU
PHARMACYTE BIOTECH, INC. Management's Discussion and Analysis of Financial Conditions and Results of Operations (form 10-Q)
AQ
PHARMACYTE BIOTECH, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan
BU
PHARMACYTE BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
PHARMACYTE BIOTECH, INC. Management's Discussion and Analysis of Financial Conditions and Results of Operations (form 10-Q)
AQ
PHARMACYTE BIOTECH, INC. : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
PHARMACYTE BIOTECH, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
PHARMACYTE BIOTECH, INC. : Change in Directors or Principal Officers, Shareholder Director Nominations, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
PHARMACYTE BIOTECH, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
AQ
PHARMACYTE BIOTECH, INC. Management's Discussion and Analysis of Financial Conditions and Results of Operations (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PMCB Stock
  4. News PharmaCyte Biotech, Inc.
  5. Press Releases